½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1493295

¹Ì±¹ÀÇ º¸Ã»±â ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç° À¯Çüº°, ±â¼úº°, ÆǸŠä³Îº°, ºÎ¹® ¿¹Ãø(2024-2030³â)

U.S. Hearing Aids Market Size, Share & Trends Analysis Report By Product Type (BTE, Canal Hearing Aids), By Technology (Digital, Analog), By Sales Channel (Retail Stores, E-pharmacy), And Segment Forecasts, 2024 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 80 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    


¡á Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¹Ì±¹ º¸Ã»±â ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¹Ì±¹ º¸Ã»±â ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 30¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç ¿¹Ãø ±â°£ µ¿¾È CAGR 5.7%·Î ¼ºÀåÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ ¼ºÀåÀº ±â¼úÀûÀ¸·Î ÷´Ü º¸Ã»±âÀÇ Ã¤¿ëÀÌ Áõ°¡ÇÏ°í ÀÖÀ¸¸ç ÀÌ ³ª¶óÀÇ ³ëÀÎ Àα¸¿¡¼­ û·Â »ó½ÇÀÇ À¯º´·üÀÌ Áõ°¡ÇÏ°í Àֱ⠶§¹®ÀÔ´Ï´Ù.

¹Ì±¹¿¡¼­´Â °í·ÉÈ­°¡ Àü·Ê¾ø´Â ¼Óµµ·Î ÁøÇàµÇ°í ÀÖÀ¸¸ç, û·Â »ó½Ç ¼ºÀÎÀÌ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. Àü¹Ì °í·ÉÀÚ ÇùÀÇȸ(National Council on Aging, Inc.)¿¡ µû¸£¸é û°¢Àå¾Ö´Â 12¼¼ ÀÌ»óÀÇ ¹Ì±¹ÀÎ ¾à 6,070¸¸¸í¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖÀ¸¸ç, 20¼¼ ÀÌ»óÀÇ ¼ºÀÎÀÇ 15.5%°¡ ¾î¶°ÇÑ ³­Ã»À» °æÇè ÇÏ°í ÀÖ½À´Ï´Ù. 65¼¼ À̻󿡼­´Â 31.1%°¡ û·Â »ó½Ç·Î, 75¼¼ À̻󿡼­´Â 40.3%·Î Áõ°¡ÇÕ´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î ¾à 7,000¸¸ ¸íÀÌ ¿ÏÀüÇÑ Ã»·ÂÀ» ¹Þ´Â ¹Ý¸é, ¹Ì±¹ ¼ºÀÎ 2,880¸¸ ¸íÀÌ º¸Ã»±â Âø¿ëÀ¸·ÎºÎÅÍ Å« ÇýÅÃÀ» ¹ÞÀ» ¼ö ÀÖ´Ù´Â Á¶»ç °á°úµµ ÀÖ½À´Ï´Ù. ±×·¯³ª À̸¸Å­ ³­Ã»ÀÌ ¸¸¿¬ÇÏ°í ÀÖÀ½¿¡µµ ºÒ±¸ÇÏ°í º¸Ã»±â¸¦ »ç¿ëÇÑ ÀûÀº 20-69¼¼·Î 16%, 70¼¼ À̻󿡼­´Â 30%¿¡ ºÒ°úÇÕ´Ï´Ù. °Ô´Ù°¡ ¹Ì±¹ÀÇ ³­Ã»·üÀº 2060³â±îÁö °ÅÀÇ µÎ ¹è°¡ µÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÇコÄÉ¾î ¾÷°è´Â ±ÔÁ¦ ¸ð´ÏÅ͸µÀ» °­È­ÇÏ°í ÀÖÀ¸¸ç ÃÖ±ÙÀÇ µ¿ÇâÀ¸·Î´Â ¹Ì±¹ ½ÄÇ°ÀǾ౹(FDA)ÀÌ ½ÃÆÇ(OTC) º¸Ã»±â °¡À̵å¶óÀÎÀ» Á¦Á¤ÇÑ °ÍÀ» µé ¼ö ÀÖ½À´Ï´Ù. º¸Ã»±â Á¦Á¶¾÷ü´Â FD&C¹ý¿¡ µû¶ó FDA°¡ Á¤ÇÑ ±ÔÁ¦¸¦ ÁؼöÇØ¾ß Çϸç, À¯ÇØ »ç·Ê º¸°í, ¶óº§¸µ, ÀüÀÚÁ¦Ç° ±ÔÁ¦ µîÀÇ ±â±â ±âÁØÀ» ¸Á¶óÇÏ°í ÀÖ½À´Ï´Ù. ƯÈ÷ ÀÌ·¯ÇÑ ±ÔÁ¦´Â OTC º¸Ã»±â¿¡µµ Àû¿ëµÇ¸ç ¶óº§¸µ, ¼º´É ¹× µðÀÚÀο¡ ´ëÇÑ ±âÁØÀ» ¼³¸íÇÕ´Ï´Ù. FD&C ¹æ¹ýÀº OTC º¸Ã»±âÀÇ °æ¿ì 21 CFR 800.30, ó¹æÀü º¸Ã»±âÀÇ °æ¿ì 21 CFR 801.422 µîÀÇ ¼½¼ÇÀ» ±ÔÁ¤ÇÏ°í Ç¥½Ã ¿ä±¸ »çÇ×À» ÁؼöÇϵµ·Ï º¸ÀåÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¤À» ÁؼöÇÏ¸é ¾ÈÀüÇÏ°í È¿À²ÀûÀÎ º¸Ã»±â¸¦ È®º¸ÇÒ ¼ö ÀÖÀ¸¸ç ¼ÒºñÀÚ´Â ÃæºÐÇÑ Á¤º¸¸¦ ¾òÀº ÈÄ º¸Ã»±â¸¦ ¼±ÅÃÇÒ ¼ö ÀÖ½À´Ï´Ù.

¹Ì±¹ º¸Ã»±â ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • Á¦Ç° À¯Çüº°·Î´Â ±Í°ÉÀÌÇü º¸Ã»±â°¡ 2023³â¿¡ 39.94%ÀÇ ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù. ÀÌ°ÍÀº ³ôÀº ³»±¸¼º°ú °ß°í¼º, Ãë±Þ ¿ëÀ̼º, ¸ðµç ¿¬·É´ë¿¡ ÀûÇÕ µîÀÇ Æ¯Â¡ ¶§¹®ÀÔ´Ï´Ù.
  • ¿îÇÏÇü º¸Ã»±â´Â ÀÚ¿¬½º·¯¿î À½Áú, ¹Ù¶÷ ¼Ò¸® °¨¼Ò, ÁöÇ⼺ °³¼±, Æí¾ÈÇÔ°ú ÆíÀǼºÀ» Á¦°øÇϱ⠶§¹®¿¡ ¿¹Ãø ±â°£ µ¿¾È ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ÆǸŠä³Îº°·Î´Â ¿Â¶óÀÎ ÆǸŠÇ÷§ÆûÀÇ ³×Æ®¿öÅ©°¡ È®¸³µÇ¾î Àֱ⠶§¹®¿¡ e-pharmacy ºÐ¾ß´Â ¿¹Ãø ±â°£ Áß¿¡ ¿Ï¸¸ÇÑ CAGRÀÌ ¿¹»óµË´Ï´Ù.
  • ±â¼úº°·Î´Â µðÁöÅÐ º¸Ã»±â ºÐ¾ß°¡ 95.19%ÀÇ Á¡À¯À²À» Â÷ÁöÇÏ°í ½ÃÀåÀ» µ¶Á¡ÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ°ÍÀº Àå±â ÀûÀÀ¼º, À½¼º °­È­, ÇϿ︵ ¾ïÁ¦, Æí¾ÈÇÔ, ½ÅÁßÇÔ µîÀÇ Æ¯Â¡ ¶§¹®ÀÔ´Ï´Ù.
  • 2024³â 1¿ù, Eargo, Inc.´Â »õ·Î¿î À̾îÆÁ µðÀÚÀÎÀ» ä¿ëÇÑ ¼¿ÇÁ ÇÇÆà ÃæÀü½Ä ½ÃÆÇ ¿îÇÏÇü º¸Ã»±â Eargo SE¸¦ Ãâ½ÃÇß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¹Ì±¹ º¸Ã»±â ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • »óÀ§ ½ÃÀå Àü¸Á
    • °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ¹Ì±¹ º¸Ã»±â ½ÃÀå ºÐ¼® µµ±¸
    • ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå ¹Ì±¹ÀÇ º¸Ã»±â ½ÃÀå : Á¦Ç° À¯ÇüÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®

  • Á¦Ç° À¯Çü ½ÃÀå Á¡À¯À², 2023³â ¹× 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ º¸Ã»±â ½ÃÀå Á¦Ç° À¯Çüº° Àü¸Á
  • 2018³âºÎÅÍ 2030³â±îÁö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× Æ®·»µå ºÐ¼®

Á¦5Àå ¹Ì±¹ÀÇ º¸Ã»±â ½ÃÀå : ±â¼ú ÃßÁ¤ ¹× µ¿Ç⠺м®

  • ±â¼ú ½ÃÀå Á¡À¯À²: 2023³â°ú 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ±â¼ú Àü¸Á¿¡ ÀÇÇÑ ¹Ì±¹ º¸Ã»±â ½ÃÀå
  • 2018³âºÎÅÍ 2030³â±îÁö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× Æ®·»µå ºÐ¼®

Á¦6Àå ¹Ì±¹ÀÇ º¸Ã»±â ½ÃÀå : ÆǸŠä³ÎÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®

  • ÆǸŠä³Î ½ÃÀå Á¡À¯À²: 2023³â°ú 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ º¸Ã»±â ½ÃÀå ÆǸŠä³Îº° Àü¸Á
  • 2018³âºÎÅÍ 2030³â±îÁö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× Æ®·»µå ºÐ¼®

Á¦7Àå °æÀï ±¸µµ

  • ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷¿¡ ÀÇÇÑ ÃÖ±ÙÀÇ µ¿Çâ°ú ¿µÇ⠺м®
  • ±â¾÷/°æÀïÀÇ ºÐ·ù
  • º¥´õ »óȲ
    • List of key distributors and channel partners
    • Key customers
    • Key company heat map analysis, 2023³â
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Sonova
    • Audicus
    • Starkey Laboratories, Inc.
    • Audina Hearing Instruments, Inc.
    • Eargo, Inc.
    • GN Store Nord A/S
    • MDHearing
    • WS Audiology
    • Horentek Hearing Diagnostics
JHS 24.06.20

U.S. Hearing Aids Market Growth & Trends:

The U.S. hearing aids market size is anticipated to reach USD 3.01 billion by 2030 and is growing at a CAGR of 5.7% during the forecast period, according to a new report by Grand View Research, Inc. This growth is attributable to the increasing adoption of technologically advanced hearing aid devices and the rising prevalence of hearing loss among the geriatric population in the country.

The U.S. population is aging faster than ever before, which is causing an increase in the number of adults with hearing loss. According to the National Council on Aging, Inc., hearing impairment affects approximately 60.7 million Americans aged 12 and older, with 15.5% of adults aged 20 and above experiencing some hearing loss. Among individuals aged 65 and older, 31.1% suffer from hearing loss, increasing to 40.3% among those aged 75 and older. Globally, around 70 million people have complete hearing loss, while studies suggest that 28.8 million American adults could benefit significantly from wearing hearing aids. However, despite the prevalence of hearing loss, only 16% of individuals aged 20-69 and 30% of those aged 70 and above have ever used a hearing aid. Moreover, hearing loss rates in the United States are projected to nearly double by 2060.

The healthcare industry has become subject to increasing regulatory scrutiny, and one recent development is the establishment of guidelines for over-the-counter (OTC) hearing aids by the U.S. Food and Drug Administration (FDA). Manufacturers of hearing aids must comply with regulations set forth by the FDA under the FD&C Act, covering device standards like adverse event reporting, labeling, and electronic product regulations. Notably, these regulations extend to OTC hearing aids, outlining criteria for labeling, performance, and design. The FD&C Act specifies sections such as 21 CFR 800.30 for OTC hearing aids and 21 CFR 801.422 for prescription hearing aids, ensuring adherence to labeling requirements. Adhering to these regulations guarantees the availability of safe and efficient hearing aids, promoting informed choices among consumers.

U.S. Hearing Aids Market Report Highlights:

  • Based on product type, the behind-the-ear hearing aid segment dominated the market with the highest revenue share of 39.94% in 2023. This is due to their features like high durability and robustness, easy to handle, and is suitable for all age groups
  • The canal hearing aids segment is expected to grow at a significant CAGR over the forecast period as they offer natural sound quality, reduced wind noise, improved directionality, and comfort & convenience
  • Based on sales channels, the e-pharmacy segment is expected to witness a moderate CAGR over the forecast period owing to the established network of online sales platforms
  • Based on technology, the digital hearing aid segment dominated the market with a share of 95.19% due to its features such as long-term adaptability, speech enhancement, feedback suppression, comfort, and discretion
  • In January 2024, Eargo, Inc. launched Eargo SE, a self-fitting, rechargeable, over-the-counter in-canal hearing aid with a new ear tip design

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product Type
    • 1.2.2. Technology
    • 1.2.3. Sales Channel
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product type outlook
    • 2.2.2. Technology outlook
    • 2.2.3. Sales channel outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Hearing Aids Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. U.S. Hearing Aids Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Hearing Aids Market: Product Type Estimates & Trend Analysis

  • 4.1. Product Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Hearing Aids Market by Product Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. In-the-ear Hearing Aids
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Receiver-in-the-ear Hearing Aids
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Behind-the-ear Hearing Aids
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Canal Hearing Aids
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Hearing Aids Market: Technology Estimates & Trend Analysis

  • 5.1. Technology Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. U.S. Hearing Aids Market by Technology Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Digital Hearing Aid
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Analog Hearing Aid
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Hearing Aids Market: Sales Channel Estimates & Trend Analysis

  • 6.1. Sales Channel Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. U.S. Hearing Aids Market by Sales Channel Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Retail Sales
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.1.2. Company Owned
      • 6.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.1.3. Independent Retail
      • 6.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. E-pharmacy
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Others
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company heat map analysis, 2023
  • 7.4. Company Profiles
    • 7.4.1. Sonova
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Audicus
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Starkey Laboratories, Inc.
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Audina Hearing Instruments, Inc.
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Eargo, Inc.
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. GN Store Nord A/S
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. MDHearing
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. WS Audiology
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Horentek Hearing Diagnostics
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦